School of Pharmaceutical Sciences, Universiti Sains Malaysia

  • Qualification

    PhD (National University of Singapore), B.Pharm (Hons) (USM)

  • Programme Chairperson & Senior Lecturer

    Discipline of Social & Administrative Pharmacy

  • Academic Editor & Editorial Board Member

    PLOS One Journal

  • Editorial Board Member

    Malaysian Journal of Pharmaceutical Sciences

  • Room

    J04 Room 101C

  • Contact

    +604-6533888 Ext. 4725

  • Email

    siewchinong@usm.my

Author ID

Ong Siew Chin, Dr

Dr Ong is currently a senior lecturer and programme chairman of Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia. She completed her PhD degree from the National University of Singapore in the field of pharmacoeconomics and outcomes research. Upon graduating from PhD, she served National University Hospital Singapore, SingHealth Centre for Health Services Research and Ministry of Health Singapore, Health Technology Assessment, Health Services Research and Evaluation Division prior return to Malaysia. She is also a registered pharmacist in both Malaysia and Singapore.

Before taking up the academic position at Universiti Sains Malaysia, she has experience working in a corporate clinical research organisation as a pharmacoeconomist and medical writer.

  • Pharmacoeconomics and outcomes research, in particular cost-effectiveness, budget impact analysis, cost analysis, cost-of-illness studies, health-related quality-of-life studies, cross-cultural adaptation and validation of questionnaires; pharmacy practice and health services research.

    1. Pharmacoeconomics and outcomes research
    2. Economic evaluation
    3. Health services research
    4. Quality of life
    5. Pharmacy practice
    1. Butt MD, Ong SC*, Butt FZ, et. al. Assessment of Health-Related Quality of Life, Medication Adherence, and Prevalence of Depression in Kidney Failure Patients. Int J Environ Res Public Health. 2022; 19(22):15266.
    2. Ong SC*, Low JZ, Yew WY, et.al. Cost analysis of chronic heart failure management in Malaysia: A multi-centred retrospective study. Front. Cardiovasc. Med. 2022. 9:971592.
    3. AOF Fadhel, Ong SC*. Cost of Illness Trends of Schizophrenia from 2010 to 2022: A Systematic Review. J Pharm Negat Result, 2022; 13(5): 970-979
    4. Butt MD, Ong SC*, Wahab MU, et. al. Cost of Illness Analysis of Type 2 Diabetes Mellitus: The Findings from a Lower-Middle Income Country. Int J Environ Res Public Health. 2022, 19, 12611.
    5. Ong SC*, Yeong SW, Tan BY, et. al. Factors Predicting Traditional and Complementary Medicine Use Among the General Public in Malaysia. Trop. J. Nat. Prod. Res. 2022; 6(7):1165-1173.
    6. Ong SC*, Shakeel S, Ooi GS. The Prevalence of Depression, Anxiety and Stress and Their Associated Factors among Malaysian Community. Med Health, 2022; 17(1): 226-245.
    7. Abu Bakar A, Ong SC*, Chuo YT, et. al. Barriers for Implementation of E-pharmacy Policy: Views of Pharmacy Authorities, Public Institutions and Societal Groups. Pertanika J. Soc. Sci. & Hum., 2022, 30 (1): 41-56.
    8. Ashraf A and Ong SC*. International Comparison of Drug Prices with Malaysia: A Systematic Review, Med Health, 2022; 17(1): 75-87.
    9. Ashraf A and Ong SC*. Value based pricing in Malaysia: A Stakeholder Analysis. Asia Pacific J. Manag, 2022; 17(2):i735.
    10. Abu Bakar A, Ong SC*, Ooi GS. A Survey on Community Pharmacists’ Interest in Providing Online Pharmacy Services. Med Health, 2022; 17(2): 181-197.
    11. Ong SC*, Vasan Thakumar A. Factors associated with dietary behaviors among Malaysian adults: Application of the Social Cognitive Theory. J. Educ. Community Health, 2022; 9(2):86-93.
    12. Ehab MM, Ong SC*, Ghadzi SMS. Efficacy and safety of sitagliptin in the treatment of COVID-19. Journal of Pharmacy Practice, 2022. Published: 17 May 2022: 1–8.
    13. Sivasankari R, Ooi GS, Ong SC*. Translation, Cross-Cultural Adaptation and Validation of the Health Belief Model Questionnaire (HBMQ) for Weight Management Behavior for use in a South East Asian country. J Pharm Health Serv Res. 2022. Published: 12 Dec 2022.
    14. Ong SC*, Low JZ, Ooi GS. Application of Health Belief Model in the Assessment of Factors Affecting Exercise Behaviours in Preventing Osteoporosis.J Pharm Health Serv Res. 2022. Published: 16 November 2022.
    15. Mohammed M, Zainal H, Ong SC, et.al. Trends in clinical prediction models of stroke outcomes research outputs: a bibliometric analysis, ASM Science Journal, 2021, 16.
    16. Yeong SW, Kon ZH, Ong SC, et. al. Engaging students in experiential learning through a public health campaign: a pre–post survey on hypertension and diabetes mellitus, Health Educ. J., 2021, 121(6):683-696.
    17. Ooi GS, Ong SC* and Kwan SM. Determinants of the choice of provisionally registered pharmacist (PRP) training in Malaysia: a qualitative insight, Int J Pharm Pract., 2021, 29(5):515-520.
    18. Ashraf A and Ong SC*. Drug price control in Malaysia: a stakeholder analysis, Int. J. Health Gov., 2021, 26(4):333-347.
    19. Shafie AA, Abu Hassan MR, Ong SC, et. al. Cost-Effectiveness Analysis of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin Regimen for Patients Infected With Chronic Hepatitis C Virus Genotype 1 in Malaysia, Value Health Reg Issues, 2020, 21:164-171.
    20. Ong SC*, Vasan Thakumar A, Ooi GS, et. al. Perspectives of the public on the consumption of unregistered health products in Malaysia, Int J Pharm Pract., 2020, 28(6):579-590.
    21. Ong SC*, Ooi GS, Shafie AA, et. al. Knowledge, attitude and disposing practice of unused and expired medicines among the general public in Malaysia, J Pharm Health Serv Res., 2020, 11(2):141-148.
    1. FAR 191: Research Methodology and Statistics in Pharmacy
    2. FAR 193: Social and Public Health Pharmacy
    3. FAR 292: Pharmaceutical Management
    4. FEL 276: Pharmaceutical Marketing
    5. FAR 391: Pharmacoepidemiology and Pharmacoeconomics in Developed Countries
    1. Cost analysis & cost-of-illness studies.
    2. Cost-effectiveness & cost-utility analyses.
    3. Budget impact analysis
    4. Health-related quality-of-life studies.
    5. Cross-cultural adaptation and validation of questionnaires.
    1. Academic Editor & Editorial Board member, PLOS One Journal
    2. Editorial Board Member, Malaysian Journal of Pharmaceutical Sciences

School of Pharmaceutical Sciences
11800 Universiti Sains Malaysia, Pulau Pinang, Malaysia.
Tel : +604-653 2211  |  Fax: +604-657 0017